Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 4 (MTND6P4) is one of several pseudogenes related to the functional mitochondrial gene MT-ND6, which encodes the NADH dehydrogenase 6 subunit of mitochondrial respiratory chain complex I. However, MTND6P4 itself is a non-coding genetic element and does not encode a functional protein. Pseudogenes like MTND6P4 arise from duplication or retrotransposition events and are distinguished by the loss of functional capacity, frequently due to sequence mutations, truncations, or absence of transcription/translation signals. While the true, protein-coding MT-ND6 gene is vital for ATP production and is involved in mitochondrial disorders[1][2][3][5], MTND6P4 has no confirmed function, therapeutic relevance, or involvement in disease. There is no evidence in major databases or scientific literature identifying MTND6P4 as a therapeutic or research target. Key factual note: Your query refers to a pseudogene (MTND6P4), not the genuine mitochondrial enzyme MT-ND6[1][2][3][5]. Pseudogenes are generally not considered targets for drug development, do not code for active proteins, and are not typically associated with physiological or pathological functions unless acting through rare regulatory or competitive RNA mechanisms (none documented for MTND6P4 specifically). If your intended interest was in the true MT-ND6 gene or its protein product—for example, as related to mitochondrial complex I or associated diseases (e.g. Leigh syndrome, Leber hereditary optic neuropathy)—please clarify, as these are distinct and biologically active molecules[1][2][3][5].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 4, mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 4 (MTND6P4).